Home Jacobio

Jacobio

In operation
Post-IPO Round
Innovative Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Jacobio is an innovative drug developer dedicated to the research and development of two projects: malignant tumors and sepsis. It has departments such as the synthesis lab, analysis lab, formulation lab, pharmacology department, QA lab, registration office, and medical department, providing users with products like novel antibody drugs and the small-molecule oral anti-tumor drug JAB-3068.
Beijing Jiakesi New Drug Development Co., Ltd.
Beijing,China
101~500 people
July 17, 2015
yuncong.zhang@jacobiopharma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Targeted Technology Protein Technology
Concept
Infectious Diseases Therapeutic Products Lung Cancer Esophageal Cancer Colorectal Cancer
Application Scenarios
Chemical Drug Targeted drugs Innovative Drugs Monoclonal Antibody